MedTrace Logo

Sevoflurane Human Biomonitoring in Operating Room Personnel

NCT03891316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-05-18

No results posted yet for this study

Summary

Sevoflurane is a widely used volatile agent for induction and maintenance of anaesthesia. The administration of sevoflurane involves the risk of occupational exposure. Possible negative implications of chronic occupational exposure to sevoflurane are not completely refuted. In Germany no maximum workplace concentration for sevoflurane is defined. This study aims to find out if working conditions of physicians and different anaesthesia techniques effect the extent of occupational exposure to sevoflurane.

Conditions

  • Occupational Exposure

Interventions

DIAGNOSTIC_TEST

HFIP and Sevoflurane are measured after 3 consecutive days of work.

Concentration of hexafluoroisopropanol and Sevoflurane are measured in urine by gas chromatography

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Katharina Roeher, Dr. med · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-11
Primary Completion
2021-03-22
Completion
2021-03-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03891316 on ClinicalTrials.gov